Stock A028300 HLB CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials HLB Co., Ltd.

Equities

A028300

KR7028300002

Medical Equipment, Supplies & Distribution

End-of-day quote Korea S.E.
Other stock markets
 06:00:00 2024-04-28 pm EDT 		5-day change 1st Jan Change
109,400 KRW -0.64% Intraday chart for HLB Co., Ltd. +2.92% +115.78%
Apr. 01 HLB Therapeutics Co.,Ltd. announced that it has received KRW 29.99999658 billion in funding from HLB Co., Ltd. CI
Mar. 22 HLB Life Science to Raise 148.5 Billion Won via Shares Issuance; Shares Decline 8% MT

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 3,122,066 4,899,577 4,887,337 3,705,375 3,303,669 6,541,974
Enterprise Value (EV) 1 3,074,478 4,935,507 4,717,379 3,656,783 3,136,065 6,492,669
P/E ratio 118 x -103 x -63.1 x -37.7 x -40.6 x -32.5 x
Yield - - - - - -
Capitalization / Revenue 86.3 x 128 x 87 x 53.1 x 18.4 x 152 x
EV / Revenue 85 x 128 x 84 x 52.4 x 17.5 x 151 x
EV / EBITDA -110 x -107 x -58.4 x -41.7 x -52.8 x -61.1 x
EV / FCF -106 x 6,075 x -36.3 x -96.4 x -64.3 x -70.6 x
FCF Yield -0.94% 0.02% -2.75% -1.04% -1.55% -1.42%
Price to Book 17.9 x 26.5 x 10.2 x 8.5 x 5.18 x 12.6 x
Nbr of stocks (in thousands) 94,142 102,737 115,724 116,605 122,143 129,033
Reference price 2 33,163 47,691 42,233 31,777 27,048 50,700
Announcement Date 3/19/19 3/20/20 3/22/21 3/22/22 3/22/23 3/21/24
1KRW in Million2KRW
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 36,186 38,421 56,177 69,826 179,708 42,901
EBITDA 1 -27,978 -46,100 -80,821 -87,775 -59,425 -106,317
EBIT 1 -29,347 -48,275 -91,312 -99,814 -75,751 -116,000
Operating Margin -81.1% -125.65% -162.54% -142.95% -42.15% -270.39%
Earnings before Tax (EBT) 1 13,503 -59,763 -93,202 -110,449 -88,411 -212,796
Net income 1 25,343 -44,386 -80,093 -98,125 -78,159 -189,079
Net margin 70.04% -115.53% -142.57% -140.53% -43.49% -440.74%
EPS 2 281.3 -464.6 -668.9 -843.3 -665.7 -1,560
Free Cash Flow 1 -28,984 812.4 -129,835 -37,952 -48,740 -91,948
FCF margin -80.1% 2.11% -231.12% -54.35% -27.12% -214.33%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/19/19 3/20/20 3/22/21 3/22/22 3/22/23 3/21/24
1KRW in Million2KRW
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 - 35,930 - - - -
Net Cash position 1 47,588 - 169,958 48,592 167,604 49,306
Leverage (Debt/EBITDA) - -0.7794 x - - - -
Free Cash Flow 1 -28,984 812 -129,835 -37,952 -48,740 -91,948
ROE (net income / shareholders' equity) 8.37% -29.9% -23.8% -20.9% -16.3% -32.2%
ROA (Net income/ Total Assets) -7.45% -9.05% -10.7% -8.6% -5.53% -8.44%
Assets 1 -340,058 490,366 750,195 1,140,516 1,412,288 2,241,578
Book Value Per Share 2 1,856 1,800 4,145 3,739 5,223 4,034
Cash Flow per Share 2 321.0 398.0 1,907 856.0 1,602 838.0
Capex 1 600 1,719 972 2,187 11,734 10,001
Capex / Sales 1.66% 4.47% 1.73% 3.13% 6.53% 23.31%
Announcement Date 3/19/19 3/20/20 3/22/21 3/22/22 3/22/23 3/21/24
1KRW in Million2KRW
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Medical Equipment, Supplies & Distribution

1st Jan change Capi.
HLB CO., LTD. Stock HLB Co., Ltd.
+115.78% 10.38B
ABBOTT LABORATORIES Stock Abbott Laboratories
-2.54% 186B
MEDTRONIC PLC Stock Medtronic plc
-1.85% 107B
BECTON, DICKINSON AND COMPANY Stock Becton, Dickinson and Company
-4.26% 67.44B
DEXCOM, INC. Stock DexCom, Inc.
+1.39% 50.03B
CENCORA, INC. Stock Cencora, Inc.
+16.82% 47.81B
HOYA CORPORATION Stock Hoya Corporation
+4.79% 41.03B
METTLER-TOLEDO INTERNATIONAL, INC. Stock Mettler-Toledo International, Inc.
+3.49% 26.85B
WEST PHARMACEUTICAL SERVICES, INC. Stock West Pharmaceutical Services, Inc.
+0.65% 25.82B
TERUMO CORPORATION Stock Terumo Corporation
+16.55% 24.74B
Other Medical Equipment, Supplies & Distribution
  1. Stock Market
  2. Equities
  3. A028300 Stock
  4. Financials HLB Co., Ltd.